Innovative medicines provide the opportunity to transform patient care, pathways, and outcomes. But how do we improve access and uptake of these medicines in a way that is affordable, and that supports the already overstretched health and care workforce.
This free online event was an opportunity to consider some of the key challenges to access and uptake of innovative medicines in England. We discussed:
the current barriers to improving access to new medicines
how to build on experiences and lessons from the rapid development, approval and rollout of vaccines and treatments as response to the Covid-19 pandemic.
We also considered what more could be done to address inequalities in uptake – especially in areas such as rare disease – and how to support and engage with an already overstretched workforce to improve uptake. Speakers discussed:
patients’ experiences, including how to address issues with variation in access and care
how we realise the potential of innovative medicine in the light of the frontline challenges NHS clinicians and patients are facing and engage in the development of new models of care to facilitate uptake.
Watch back on demand
Samantha BarberChief Executive, Gene People
Louise FishChief Executive, Genetic Alliance
- Former Chief Executive
Guy OliverGeneral Manager, UK and Ireland, Ipsen
Sharmila Nebhrajani OBEChairman, NICE
Dr Richard RoopeWessex Rapid Investigation Service GP and Wessex Cancer Alliance GP Adviser